Elbit Imaging Valuation

Q: What is the Fair Price of EMIT.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

EMIT.F ($1.01) is trading above our estimate of [[fair value]] ($0.56)

Is EMIT.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of EMIT.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: EMIT.F ($1.01) is trading above our estimate of fair value ($0.56)

Significantly Below Fair Value: EMIT.F is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for EMIT.F?

Key metric: As EMIT.F barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for EMIT.F. This is calculated by dividing EMIT.F's market cap by their current book value.
What is EMIT.F's PB Ratio?
PB Ratio	0.8x
Book	₪70.62m
Market Cap	₪55.33m

EMIT.F key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	40.4x
Enterprise Value/EBITDA	n/a
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does EMIT.F's PB Ratio compare to its peers?

The above table shows the PB ratio for EMIT.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	11.6x
XAIR Beyond Air	1.3x	15.7%	US$36.2m
PETV PetVivo Holdings	26.3x	n/a	US$10.0m
LFWD Lifeward	0.5x	65.0%	US$15.8m
RMSL REMSleep Holdings	18.5x	n/a	US$10.5m
EMIT.F Elbit Imaging	0.8x	n/a	US$55.3m

Price-To-Book vs Peers: EMIT.F is good value based on its Price-To-Book Ratio (0.8x) compared to the peer average (10.8x).

Price to Book Ratio vs Industry

How does EMIT.F's PB Ratio compare vs other companies in the US Medical Equipment Industry?

29 Companies	Price / Book	Estimated Growth	Market Cap
RVP Retractable Technologies	0.2x	n/a	US$18.41m
LFWD Lifeward	0.5x	65.0%	US$15.79m
HLTH Cue Health	0.06x	51.0%	US$14.72m
MHUA Meihua International Medical Technologies	0.09x	n/a	US$12.37m

29 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: EMIT.F is good value based on its Price-To-Book Ratio (0.8x) compared to the US Medical Equipment industry average (2.4x).

Price to Book Ratio vs Fair Ratio

What is EMIT.F's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

EMIT.F PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	0.8x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate EMIT.F's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Elevance Health

US$92.9b

Operates as a health benefits company in the United States.

ELV

US$400.70

-5.8%

-13.9%

CVS Health

US$66.9b

Provides health solutions in the United States.

CVS

US$56.05

0.4%

-17.9%

Patterson Companies

US$1.7b

Engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada.

PDCO

US$20.90

-0.7%

-34.7%